Do Self-Rated Performance Status Scores Correlate With Health-Care-Provider-Scores?

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-02-29

Study Completion Date

2011-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if patients are able to self-rate their physical abilities and how these ratings compare to the ratings of their health-care provider.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessment of the Clinic-pathological Correlation of Basal Cell Carcinoma

NCT02825511

Basal Cell Carcinoma

COMPLETED

Significant Pathology Associated With Crossed Leg Sign

NCT01569555

Pathology

UNKNOWN

Crossed Leg Sign and it's Correlation With Significant Pathology

NCT01569542

Pathology

UNKNOWN

Handgrip Strength (HGS) With HGS Asymmetry Are Associated With All-cause Mortality and Hospital Readmissions

NCT05397444

Gastric Cancer

COMPLETED

Hematuria Evaluation Trial for Subjects With Microscopic or Gross Hematuria to Determine the Absence or Presence of Bladder Cancer

NCT00975455

Microscopic or Gross Hematuria

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Karnofsky Performance Scale (KPS) is a highly validated and essential measuring tool across the cancer population. The scale relates to purely physical ability and covers 11 stages, ranging from normal health to death, with each stage scored as a percentage. The score is determined by the health-care provider and is based on observation and narrative patient descriptions. The purpose of this study is to compare the scores rated by the health-care provider to the scores that patients assign to themselves.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Karnofsky Performance Status Score

Group Type EXPERIMENTAL

Karnofsky Performance Status Score

Intervention Type OTHER

Karnofsky Performance Status scores will be independently completed by both the patient and their health-care provider at each routine clinic visit.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Karnofsky Performance Status Score

Karnofsky Performance Status scores will be independently completed by both the patient and their health-care provider at each routine clinic visit.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Performance Status Scale

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with a diagnosis of brain or spinal tumor.
* Receiving medical care under the supervision of the Principal Investigator.
* Written informed consent.